DRI HEALTHCARE TRUST (DHT-U.CA) Stock Price, Forecast & Analysis

TSX:DHT-U • CA23344H1091

11.68 USD
-0.77 (-6.18%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News

DHT-U.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap643.68M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Shares55.11M
Float54.60M
52 Week High12.5
52 Week Low7.65
Yearly DividendN/A
Dividend Yield4.57%
EPS(TTM)2.25
PE5.19
Fwd PE5.09
Earnings (Next)03-02
IPO2021-02-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
DHT-U.CA short term performance overview.The bars show the price performance of DHT-U.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

DHT-U.CA long term performance overview.The bars show the price performance of DHT-U.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80 100

The current stock price of DHT-U.CA is 11.68 USD. In the past month the price increased by 1.57%. In the past year, price decreased by -6.78%.

DRI HEALTHCARE TRUST / DHT-U Daily stock chart

DHT-U.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to DHT-U.CA. When comparing the yearly performance of all stocks, DHT-U.CA turns out to be only a medium performer in the overall market: it outperformed 60.23% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
DHT-U.CA Full Technical Analysis Report

DHT-U.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.333.019B
CRON CRONOS GROUP INC36.471.372B
TLRY TILRAY BRANDS INC N/A1.213B
DHT-UN DRI HEALTHCARE TRUST7.13923.524M
GUD KNIGHT THERAPEUTICS INC129.86625.948M
WEED CANOPY GROWTH CORP N/A597.979M
NGEN NERVGEN PHARMA CORP N/A458.223M
CPH CIPHER PHARMACEUTICALS INC27.65381.475M
TSND TERRASCEND CORP N/A304.466M

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges

DRI HEALTHCARE TRUST / DHT-U.CA FAQ

What does DHT-U do?

DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.


What is the stock price of DRI HEALTHCARE TRUST today?

The current stock price of DHT-U.CA is 11.68 USD. The price decreased by -6.18% in the last trading session.


How is the ChartMill rating for DRI HEALTHCARE TRUST?

DHT-U.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.